(ED) are also thought to be frequent but there is scant empirical evidence enumerating these. (1,2) Few studies have described the impacts of rare complex and chronic disease on health services nor the impacts on families. We aimed to describe the use of health services and barriers experienced when accessing services among a cohort of 462 children living with rare complex and chronic according disease, according to health functioning and geographical location.
Methods: As described in our previous publication, families were recruited from lists held by rare disease support organisations, The Steve Waugh Foundation, The SMILE Foundation (now part of Variety the Children's Charity) and the Australian Genetic Alliance (formerly Association of Genetic Support Australasia) and a large state-wide clinic, the Genetic Metabolic Disorders Service. (3) Parents completed a comprehensive survey which included the Measure of Function (MOF) developed for ages 0-18 years. (4) Parents provided information about visits to health professionals, hospital admissions, ED presentations and barriers experienced including out-of-pocket costs, waiting times, travel and loss of household income when accessing services. The family post-code was classified according to the Australian Standard Geographical Classification (ASGC). (5) Results: Parents of 462 children who had over 270 different rare diseases completed the survey. (3) Health functioning was not affected or mildly affected in 39%, moderately affected in 54% and severely affected in 7%. In 12 months the children accounted for 3163 GP visits, 3540 visits to specialists and 10,094 visits to allied health professionals. There were 1231 admissions in 12 months, or 2.7 admissions per child per annum, which is 45 times higher than the estimated general population rate of 0.06 admissions per child per annum. There were 1.4 ED presentations per child per annum, about 8 times higher than the population based estimate of 0.18 per child per annum. The total cost of admissions and ED presentations per annum is estimated at $8,771,082 for the 347 children admitted or presenting to ED, or on average $25,277 per child per annum. Children whose health functioning was moderately or severely affected were significantly more likely to be admitted (Chi 2 =257.4; P<0.001) or to present to ED (Chi 2 =198.2; P<0.0001). Most children (75%) lived in major cities. Children living in regional or remote areas experienced multiple barriers when accessing health services more often than children living in major cities (Chi 2 =35.1; P<0.0001), including distance to travel, out-of-pocket costs and lack of services. Families from regional and remote Australia were less likely to have private health insurance (Chi 2 =12.2; P<0.01) and spent significantly more in out-of-pocket costs while seeking a diagnosis for their child ($2604 major cities, $5390 regional areas, $9250 remote areas; F=3.53; P<0.05).
Conclusions: Although there are relatively few children diagnosed with rare chronic conditions in the population they have an enormous impact on health services, prompting the need for integration of services and patient centred care to meet the needs of individual patients and families within their individual context. . We aimed to investigate the impact on decision making of bedside influenza POCT in the ED performed by the clinician.
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Methods: We retrospectively evaluated all children for whom bedside POCT (BD Veritor ® ) was performed at a tertiary paediatric emergency department in the influenza season in 2017 (July to early October). Our primary outcome measures were LOS in the ED and in the hospital for those admitted. Our secondary outcome measures were rate of admission, rate of investigations and of serious bacterial infections. Results: One hundred thirty five patients had bedside POCT for influenza and were included in our study. Average age was 4 years, with 47% females and 34% of patients were admitted. Seventy two (53%) had a negative bedside result, 38(28%) results showed influenza A and 25(18%) influenza B. Of those discharged 44(50%) had a positive influenza result and in admitted patients 19(40%) had a positive result. Median length of stay in ED was 5.3hours, with longer length of stay among admitted compared with discharged patients (6.9hours vs. 4.4hours accordingly).
Patients with a positive influenza bedside POCT had a significantly shorter on length of stay in ED (median 4.7vs. 6.4hours, p<0.01 ttest). The ED length of stay was seen to be significantly lower in admitted patients (6.1 vs. 8 hours, p<0.05) and in discharged patients (4.3vs. 4.8hours) but did not reach significance in this last group. Reviewing the use of other tests in our cohort 39 patients (19%) had a blood culture taken (with one positive result in a patient with a negative influenza result), 23(17%) had urine sample collected (with three positive results one associated with a positive influenza result) and one patient (0.7%) underwent lumbar puncture which was clear. There was no significant difference in the rate of microbiology testing in patients who had a positive POCT influenza test compared with patients with a negative influenza POCT test (chi squared test).
Conclusion: Positive influenza bedside test results were associated with a shorter time patients spent in ED particularly in those subsequently admitted. This aided the flow of patients through ED during the busy winter season. It is thought this is related to the impact of a rapid result on decision making in the assessment of the patient. In our population, there were no cases of bacteraemia or meningitis associated with a positive influenza result. One child had a urinary tract infection and a positive influenza result. Background: Urinary tract infection (UTI) is one of the most common bacterial infections of early childhood, and many febrile children require a urine sample to diagnose or exclude UTI. Collecting urine from a young pre-continent child however is challenging. Collection attempts are often time-consuming or unsuccessful and samples can be contaminated. The costs of collecting urine to evaluate UTI in pre-continent children presenting to hospital are not known.
Objective: To determine the costs and cost effectiveness of commonly used urine collection methods, including non-invasive (urine bag, clean catch, 5 minute voiding stimulation for clean catch) and invasive (urethral catheterization, suprapubic aspirate) methods, for children aged 0-24 months in the Emergency Department.
Methods: A probabilistic decision analytic model was used to synthesise data from published local studies and international literature using an Australian healthcare system perspective. Model inputs were validated by surveying 20 expert clinicians. Cost analysis for each method was performed using process mapping to record resource use. For each method we derived the costs of the initial collection attempt including equipment, staff time and hospital bed occupancy (phase 1), and if the initial attempt was unsuccessful to obtain a urine sample by catheter (phase 2). We then derived the costs of collecting an ultimately definitive sample incorporating the progressive dipstick, culture results and rate of contamination to reach a conclusive clinical decision (phase 3). To determine the robustness of model assumptions and account for uncertainty in parameter values, we performed deterministic sensitivity and counterfactual analyses, based on variables likely to have a significant impact on the model conclusions.
Results: Catheterization is likely to be the most cost-effective method for initial urine sample collection attempts. Catheterization also had the lowest costs for obtaining a definitive sample. For non-invasive methods, 5 minute voiding stimulation was the most cost-effective for initial collection attempts, and the lowest cost to obtain a definitive sample. Urine bags were the least costeffective method with the highest costs for obtaining a definitive sample.
Conclusion: From a healthcare system costs perspective, catheterization is the favoured method of urine collection from young children. If invasive sample collection is not suitable, 5 minute voiding stimulation is the favoured non-invasive method. Urine bags are the most costly of all collection methods. While other clinical factors influence the choice of urine collection method, considering the costs and cost-effectiveness of this common paediatric procedure has the potential for aggregate health service savings. 
